Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × INDUSTRY × Solid Neoplasms × Clear all

Phase

Phase 1/2 1 Phase 1 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 368 Neoplasms 300 Breast Neoplasms 216 Colorectal Neoplasms 197 Neoplasm Metastasis 169 Melanoma 168 Leukemia, Myeloid, Acute 162 Pancreatic Neoplasms 151 Multiple Myeloma 151 Ovarian Neoplasms 150 Recurrence 142 Prostatic Neoplasms 124 Lymphoma, Non-Hodgkin 116 Stomach Neoplasms 114 Squamous Cell Carcinoma of Head and Neck 103 Lymphoma 102 Lung Neoplasms 102 Carcinoma, Hepatocellular 96 Leukemia, Lymphocytic, Chronic, B-Cell 85 Advanced Solid Tumor 84 Carcinoma, Renal Cell 83 Leukemia 80 Triple Negative Breast Neoplasms 79 Glioblastoma 77 Head and Neck Neoplasms 74 Lymphoma, Large B-Cell, Diffuse 71 Small Cell Lung Carcinoma 69 Myelodysplastic Syndromes 67 Endometrial Neoplasms 64 Advanced Solid Tumors 63

Interventions

pembrolizumab 1 Platinum 1 Fluorouracil 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04420884 2025-06-13

iintune-1

Takeda

Phase 1/2 Active not recruiting

Solid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡